RSV Vaccine Displays Effectiveness Against RSV-Associated Hospitalizations
RSV vaccination is approximately 77% to 81% effective against hospital and emergency department encounters among older adults.
Related Articles
Designing a Legacy — Portraiture as a Tool for Disrupting Structural Sexism and Racism | NEJM
A gallery of portraits of prominent alumnae of color at Harvard Medical School provides inspiration for diverse current students and makes past sexist practices visible…
Study: Low Number of Patients With Chronic Respiratory Diseases Received Annual Flu Vaccination
In the analysis, 34.7% of commercially insured patients with chronic obstructive pulmonary disease or asthma received an influenza vaccination.
Best (and Worst) Ways To Sweeten Your Food
When it comes to satisfying your sweet tooth, some sweeteners are better than others. What makes sugar a risk for your health, and what are…
STK19 facilitates the clearance of lesion-stalled RNAPII during transcription-coupled DNA repair
STK19 functions in transcription-coupled DNA repair, aiding the clearance of RNAPII and advancing the repair process by positioning the ATPase subunits of TFIIH onto DNA.
Guiding while growing: The dual role of early career mentors
Click on the article title to read more.
5 Key Interviews, New Data at the American Heart Association 2024 Scientific Sessions
The sessions will include late-breaking science, clinical practice guidelines, early innovators spotlight sessions, and more.
Codesign and evaluation of advanced therapeutic information resources for and with families of children with neurological conditions: a mixed methods cross-sectional study
Objective Parents and caregivers of children with neurological conditions express interest in new and developing treatments and trials; however, they have limited knowledge of, and…
Timing of Neonatal Discharge and Readmission to PICUs Among Preterm Infants
This cohort study examines whether the season and postmenstrual age of preterm infants discharged from neonatal units are associated with unplanned readmission to pediatric intensive…
FDA Approves Eladocagene Exuparvovec-Tneq for Treatment of AADC Deficiency
Eladocagene exuparvovec-tneq is the first FDA-approved gene therapy for individuals with aromatic L-amino acid decarboxylase deficiency.
Digital Innovation to Grow Quality Care Through an Interprofessional Care Team (DIG IT) Among Underserved Patients With Hypertension
PURPOSE The impact of digital health on medically underserved patients is unclear. This study aimed to determine the early impact of a digital innovation to…
